Immediate Impact
57 standout
Citing Papers
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Works of M. Marcq being referenced
Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| M. Marcq | 143 | 81 | 26 | 30 | 28 | 188 | |
| Maxime Dewolf | 86 | 65 | 28 | 20 | 26 | 169 | |
| Taichi Miyawaki | 165 | 213 | 21 | 64 | 35 | 280 | |
| Mariko Asano | 141 | 120 | 14 | 24 | 33 | 264 | |
| Hisao Higo | 147 | 76 | 11 | 28 | 38 | 196 | |
| Dragana Jovanović | 89 | 56 | 11 | 36 | 35 | 149 | |
| Hiroaki Ihara | 176 | 61 | 17 | 44 | 27 | 287 | |
| Alison Turner | 91 | 55 | 12 | 23 | 24 | 212 | |
| Ioannis Tomos | 235 | 27 | 9 | 32 | 27 | 290 | |
| Yuki Takeyasu | 130 | 163 | 31 | 7 | 28 | 229 | |
| Tashnin Rahman | 66 | 65 | 21 | 24 | 31 | 261 |
All Works
Login with ORCID to disown or claim papers
Loading papers...